Correlation Between NeuroSense Therapeutics and Gilead Sciences

Can any of the company-specific risk be diversified away by investing in both NeuroSense Therapeutics and Gilead Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NeuroSense Therapeutics and Gilead Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NeuroSense Therapeutics Ltd and Gilead Sciences, you can compare the effects of market volatilities on NeuroSense Therapeutics and Gilead Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NeuroSense Therapeutics with a short position of Gilead Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of NeuroSense Therapeutics and Gilead Sciences.

Diversification Opportunities for NeuroSense Therapeutics and Gilead Sciences

-0.47

Correlation Coefficient

NeuroSense Therapeutics  Gilead Sciences

Very good diversification

The 3 months correlation between NeuroSense and Gilead is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding NeuroSense Therapeutics Ltd and Gilead Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gilead Sciences and NeuroSense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NeuroSense Therapeutics Ltd are associated (or correlated) with Gilead Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gilead Sciences has no effect on the direction of NeuroSense Therapeutics i.e., NeuroSense Therapeutics and Gilead Sciences go up and down completely randomly.

Pair Corralation between NeuroSense Therapeutics and Gilead Sciences

Assuming the 90 days horizon NeuroSense Therapeutics Ltd is expected to under-perform the Gilead Sciences. In addition to that, NeuroSense Therapeutics is 14.77 times more volatile than Gilead Sciences. It trades about -0.24 of its total potential returns per unit of risk. Gilead Sciences is currently generating about -0.32 per unit of volatility. If you would invest  6,955  in Gilead Sciences on February 4, 2024 and sell it today you would lose (477.00) from holding Gilead Sciences or give up 6.86% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	65.22%
Values	Daily Returns

NeuroSense Therapeutics Ltd  vs.  Gilead Sciences

NeuroSense Therapeutics

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in NeuroSense Therapeutics Ltd are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, NeuroSense Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Gilead Sciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Gilead Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in June 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with NeuroSense Therapeutics and Gilead Sciences

The main advantage of trading using opposite NeuroSense Therapeutics and Gilead Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NeuroSense Therapeutics position performs unexpectedly, Gilead Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gilead Sciences will offset losses from the drop in Gilead Sciences' long position.

The idea behind NeuroSense Therapeutics Ltd and Gilead Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.